About Adicare Pharmaceuticals Private Limited
Data last updated:
Adicare Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 14 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2020PTC043153. Its GSTIN is 04AATCA8562D1ZI (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhupendra Kumar and Punam Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 357, Industrial Area Phase 2 Chandigarh, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.63 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹3.42 Lakh (net margin -94.4%) and EBITDA of -₹3.21 Lakh (EBITDA margin -88.6%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years.
For more details, the company can be reached via its website adicarepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 357, Industrial Area Phase 2 Chandigarh, Chandigarh, India – 160002
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Adicare Pharmaceuticals Private Limited
The main business activity of Adicare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Adicare Pharmaceuticals Private Limited FY 2025 filings available
Adicare Pharmaceuticals Private Limited reported revenue of ₹3.63 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Adicare Pharmaceuticals Private Limited
Revenue fell 11% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Adicare Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.21 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.42 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Adicare Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -88.6% | •••• | •••• | •••• |
| Net Profit Margin | -94.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Adicare Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adri Pharmaceuticals Private Limited | ₹3.67 Lakh (FY 2022) | •••• | •••• | -2.0% | •••• | Muzaffarpur, Bihar, India |
| Ventriva Pharmaceuticals India Private Limited | ₹3.67 Lakh (FY 2023) | •••• | •••• | 132.0% | •••• | Patna, Bihar, India |
| Vaxxon Pharmaceuticals Private Limited | ₹3.67 Lakh (FY 2024) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Geesk Pharmaceuticals Private Limited | ₹3.66 Lakh (FY 2020) | •••• | •••• | •••• | Bareilly, Uttar Pradesh, India | |
| Shyok Pharmaceuticals Private Limited | ₹3.63 Lakh (FY 2025) | •••• | •••• | 1070.0% | •••• | Sihora, Madhya Pradesh, India |
| Adicare Pharmaceuticals Private Limited this company | ₹3.63 Lakh (FY 2024) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Alef Pharmaceuticals Private Limited | ₹3.63 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Lucknow, Uttar Pradesh, India |
| Alcysto Pharmaceuticals Private Limited | ₹3.61 Lakh (FY 2024) | •••• | •••• | •••• | Ranchi, Jharkhand, India | |
| Shinehealth Pharmaceuticals Private Limited | ₹3.6 Lakh (FY 2022) | •••• | •••• | 55.0% | •••• | Ranchi, Jharkhand, India |
| Hermatic Pharmaceuticals Pvt Ltd | ₹3.6 Lakh (FY 2019) | •••• | •••• | 10.0% | •••• | Vadodara, Gujarat, India |
| Dreamland Pharmaceuticals Management Private Limited | ₹3.6 Lakh (FY 2018) | •••• | •••• | •••• | Bhograi, Odisha, India |
Peers are the five companies nearest above and the five nearest below Adicare Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupendra Kumar | Director | 14 Aug 2020 | 6 Years 1 Months | Current |
| Punam Singh | Director | 14 Aug 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of Adicare Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bhupendra Kumar was appointed as Director on 14 Aug 2020.
Credit Ratings, Litigation & Regulatory Alerts for Adicare Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Adicare Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Adicare Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AATCA8562D1ZI | Chandigarh | Active | 23 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Adicare Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adicare Pharmaceuticals Private Limited
Adicare Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in specialty, within the trading industry. It was incorporated on 14 August 2020 (6+ years old) and is registered under CIN U51909CH2020PTC043153.
Adicare Pharmaceuticals reported revenue of ₹3.63 Lakh for FY 2024 (down 11% YoY).
Adicare Pharmaceuticals has 2 current directors:
- Bhupendra Kumar - Director
- Punam Singh - Director
Adicare Pharmaceuticals reported a net loss of ₹3.42 Lakh (net margin -94.4%) and EBITDA of -₹3.21 Lakh (EBITDA margin -88.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Adicare Pharmaceuticals is 33% over three years. In the latest year (FY 2024) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Adicare Pharmaceuticals is 04AATCA8562D1ZI, registered in Chandigarh.
The CIN (Corporate Identification Number) of Adicare Pharmaceuticals is U51909CH2020PTC043153. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adicare Pharmaceuticals was incorporated on 14 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Adicare Pharmaceuticals by revenue are Adri Pharmaceuticals Private Limited, Ventriva Pharmaceuticals India Private Limited, Vaxxon Pharmaceuticals Private Limited, Geesk Pharmaceuticals Private Limited, Shyok Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Bhupendra Kumar was appointed as Director on 14 Aug 2020. Punam Singh was appointed as Director on 14 Aug 2020.
Adicare Pharmaceuticals can be reached through the website adicarepharma.com. Its registered office is in Chandigarh, India.